When the Creation of a Consortium Provides Useful Answers: Experience of The Latin American DILI Network (LATINDILIN)-Reference-Cited by-同舟云学术

When the Creation of a Consortium Provides Useful Answers: Experience of The Latin American DILI Network (LATINDILIN)

Published:2019-02 Issue:2 Volume:13 Page:51-57
ISSN:2046-2484
Container-title:Clinical Liver Disease
language:en
Short-container-title:Clinical Liver Disease

Author:

Bessone Fernando¹,Hernandez Nelia²,Mendizabal Manuel³,Sanchez Adriana²,Paraná Raymundo⁴,Arrese Marco⁵^ORCID,Tagle Martin⁶,Girala Marcos⁷,Lizarzabal Maribel⁸,Carrera Enrique⁹,Brahm Javier⁵,Contreras Fernando¹⁰,Mendez‐Sanchez Nahum¹¹,Santos Genario⁴,Nunes Vinicius⁴,Medina‐Caliz Inmaculada¹²,Parra‐Martinez Cecilio¹²^ORCID,Sanz‐Villanueva Laura¹²^ORCID,Isabel Lucena Maria¹²,Andrade Raul J.¹²

Affiliation:

1. Hospital Provincial del Centenario, University of Rosario School of Medicine Rosario Argentina

2. Hospital de Clínicas Montevideo Uruguay

3. Hospital Universitario Austral Pilar, Buenos Aires Argentina

4. Hospital Universitario Prof. Edgard Santos Salvador de Bahia Brazil

5. Universidad Católica Pontificia de Chile Santiago Chile

6. Clínica Angloamericana Lima Perú

7. Hospital de Clínicas Asunción del Paraguay Paraguay

8. Hospital Universitario de Maracaibo Maracaibo Venezuela

9. Hospital de Especialidades Eugenio Espejo Quito Ecuador

10. Universidad Nacional Pedro Henriquez Santo Domingo República Dominicana

11. Fundación Clínica Médica Sur Mexico City Mexico

12. Unidad de Gestión Clínica de Ap Digestivo y Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga Hospital Universitario Virgen de la Victoria, Universidad de Málaga Málaga Spain

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cld.778

Reference18 articles.

1. Drug-induced liver injury: recent advances in diagnosis and risk assessment

2. Causality assessment methods in drug induced liver injury: Strengths and weaknesses

3. Building a Spanish Latin American network on drug induced liver injury: Much to get from a joint collaborative initiative;Bessone F;Ann Hepatol,2012

4. Creating an effective clinical registry for rare diseases

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the therapeutic promise of natural products in alleviating drug‐induced liver injury: Present advancements and future prospects;Phytotherapy Research;2023-09-29

2. AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury;Hepatology;2023-02-17

3. Sex disparity and drug-induced liver injury;Digestive and Liver Disease;2023-01

4. Influence of Antibiotics on Functionality and Viability of Liver Cells In Vitro;Current Issues in Molecular Biology;2022-10-03

5. Modeling drug-induced liver injury: current status and future prospects;Expert Opinion on Drug Metabolism & Toxicology;2022-09-02